Evidence map›Paper›PMID 37383459›Full record

ArticleBrain & spine2023

Safety and efficacy of brain biopsy: Results from a single institution retrospective cohort study.

Felix Jozsa, Celia Gaier, Yangxinrui Ma, Neil Kitchen, Andrew McEvoy, Anna Miserocchi, George Samandouras, Huma Sethi, Lewis Thorne, Ciaran Hill and 1 more

Open access · goldAbstract read
In one paragraph

Article in Brain & spine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Isolation and Characterization of Cell-Free DNA from Cerebral Organoids.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Felix JozsaDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Celia GaierUniversity College London Medical School, London, UK.
Yangxinrui MaUniversity College London Medical School, London, UK.
Neil KitchenDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Andrew McEvoyDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Anna MiserocchiDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
George SamandourasDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Huma SethiDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Lewis ThorneDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Ciaran HillDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Lucia DarieDepartment of Neurosurgery, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Trust, London, UK.
Royal London Hospital · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Brain biopsy provides important histopathological diagnostic information for patients with new intracranial lesions. Although a minimally invasive technique, previous studies report an associated morbidity and mortality between 0.6% and 6.8%. We sought to characterise the risk linked to this procedure, and to establish the feasibility of instigating a day-case brain biopsy pathway at our institution. Materials and methods: This single-centre retrospective case series study included neuronavigation guided mini craniotomy and frameless stereotactic brain biopsies carried out between April 2019 and December 2021. Exclusion criteria were interventions performed for non-neoplastic lesions. Demographic data, clinical and radiological presentation, type of biopsy, histology and complications in the post-operative period were recorded. Results: Data from 196 patients with a mean age of 58.7 years (SD+/-14.4 years) was analysed. 79% (n=155) were frameless stereotactic biopsies and 21% (n=41) neuronavigation guided mini craniotomy biopsies. Complications resulting in acute intracerebral haemorrhage and death, or new persistent neurological deficits were observed in 2% of patients (n=4; 2 frameless stereotactic; 2 open). Less severe complications or transient symptoms were noted in 2.5% of cases (n=5). 8 patients had minor haemorrhages in the biopsy tract with no clinical ramifications. Biopsy was non-diagnostic in 2.5% (n=5) of cases. Two cases were subsequently identified as lymphoma. Other reasons included insufficient sampling, necrotic tissue, and target error. Discussion and conclusion: This study demonstrates that brain biopsy is a procedure with an acceptably low rate of severe complications and mortality, in line with previously published literature. This supports the development of day-case pathway allowing improved patient flow, reducing the risk of iatrogenic complications associated with hospital stay, such as infection and thrombosis.

Indexed as

Brain biopsyDay-case pathwayOpen biopsyPost-operative complication rateprimary CNS tumourStereotactic frameless

Identifiers

PMID37383459
PMCPMC10293303
OpenAlexW4380372825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.